Kalehua Capital Management »

Nuvectis Pharma shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 100k 18.39

More positions owned by Kalehua Capital Management

Ea Series Trust Alpha Arch 1-3 (BOXX)
Veradermics Common Stock (MANE)
Veradermics Coomon Stock (MANE)
X4 Pharmaceuticals Com New (XFOR)
X4 Pharmaceuticals Com New (XFOR)
Compass Pathways Sponsored Ads (CMPS)
Compass Pathways Sponsored Ads (CMPS)
Surrozen Com New (SRZN)
Surrozen Com New (SRZN)
Aclaris Therapeutics (ACRS)
Aclaris Therapeutics (ACRS)
Sionna Therapeutics (SION)
Sionna Therapeutics (SION)
Inhibikase Therapeutics Com New (IKT)
Inhibikase Therapeutics Com New (IKT)

View all positions for Kalehua Capital Management

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma